Loop Diuretics Unique Mechanism of Action

• Published in: Journal of the Association of Physicians of India Vol. 72; no. 9S; p. 14
• Main Authors: Solanki, Dharmesh, Choudhary, Sarita, Vora, Agam, Ghose, Tapan, Mantri, R R, Modi, Nitin, Sawhney, Jps, Singhal, Anurag, Kumar, Anand, Edakutty, Rajeev, Pande, Arindam, Ahuja, Ramandeep, Francis, Febin, Mohanasundaram, Senthilnathan
• Format: Journal Article
• Language: English
• Published: 01.09.2024
• ISSN: 0004-5772
• DOI: 10.59556/japi.72.0670

Loop diuretics, including torsemide, furosemide, bumetanide, and piretanide, act by inhibiting the sodium-potassium-chloride (Na+/K+/2Cl-) cotransporter in the thick ascending limb of the loop of Henle within the nephron. This mechanism is pivotal in managing fluid retention associated with conditions such as heart failure, cirrhosis, chronic kidney disease, and hypertension. A comprehensive understanding of how these diuretics uniquely target this transporter provides crucial insights into effectively addressing fluid overload across diverse clinical conditions.Loop diuretics, including torsemide, furosemide, bumetanide, and piretanide, act by inhibiting the sodium-potassium-chloride (Na+/K+/2Cl-) cotransporter in the thick ascending limb of the loop of Henle within the nephron. This mechanism is pivotal in managing fluid retention associated with conditions such as heart failure, cirrhosis, chronic kidney disease, and hypertension. A comprehensive understanding of how these diuretics uniquely target this transporter provides crucial insights into effectively addressing fluid overload across diverse clinical conditions.